Quinoline derivatives and quinazoline derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 30, 2007
Issued Date -
N/A
app pub date -
May 10, 2004
filing date -
Jan 22, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
An object of the present invention is to provide compounds which have antitumor activity and do not change cytomorphosis. Disclosed are compounds represented by formula (I) and a pharmaceutically acceptable salts and solvates thereof and pharmaceutical compositions comprising said compounds: ##STR00001## wherein X and Z each independently represent CH or N; R.sup.1 to R.sup.3 represent H, substituted alkoxy, unsubstituted alkoxy or the like; R.sup.4 represents H; R.sup.5 to R.sup.8 represent H, halogen, alkyl, alkoxy, alkylthio, nitro, or amino, provided that R.sup.5 to R.sup.8 do not simultaneously represent H; R.sup.9 and R.sup.10 represent H, alkyl, or alkylcarbonyl; and R.sup.11 represents alkyl, alkenyl, alkynyl, or aralkyl.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully